Specifically, the CSF1R inhibitor pexidartinib suppresses survival, migration, and M2 polarization of sarcoma TAMs in vitro and significantly inhibits osteosarcoma growth and metastatic spread in vivo, in a syngeneic murine model (96). This evidence concerns the gene CSF1R and sarcoma.